3.90
0.00%
+0.00
アフターアワーズ:
3.91
0.01
+0.26%
Geron Corp. (GERN) 最新ニュース
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Business Wire
New York State Common Retirement Fund Boosts Stake in Geron Co. (NASDAQ:GERN) - Defense World
Defense World
Russell Investments Group Ltd. Buys 204765 Shares of Geron Co. (NASDAQ:GERN) - Defense World
Defense World
Geron Co. (NASDAQ:GERN) is Vivo Capital LLC's 7th Largest Position - MarketBeat
MarketBeat
Geron (NASDAQ:GERN) Stock Price Down 4.3% - MarketBeat
MarketBeat
ERS International Congress 2016 - imetelstat, Research - The Pharma Letter
The Pharma Letter
Geron (NASDAQ:GERN) Given “Buy” Rating at Needham & Company LLC - Defense World
Defense World
Geron (NASDAQ:GERN) Rating Lowered to Neutral at Robert W. Baird - Defense World
Defense World
Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Geron (GERN) Q1 2024 Earnings Call Transcript - The Motley Fool
The Motley Fool
Geron (GERN) Q1 2024 Earnings Call Transcript
The Motley Fool
Geron: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Yahoo Finance
Short Interest in Geron Co. (NASDAQ:GERN) Grows By 5.9% - MarketBeat
MarketBeat
Baird analyst downgrades Geron stock to neutral, forecasts limited upside - Investing.com
Investing.com
Navigating 10 Analyst Ratings For Geron
Benzinga
Geron (NASDAQ:GERN) Coverage Initiated by Analysts at TD Cowen - MarketBeat
MarketBeat
3 'Buy-Rated' Biotech Stocks Under $10
Seeking Alpha
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024 - Business Wire
Business Wire
With 55% ownership in Geron Corporation (NASDAQ:GERN), institutional investors have a lot riding on the business - Simply Wall St
Simply Wall St
Arizona State Retirement System Sells 20647 Shares of Geron Co. (NASDAQ:GERN) - Defense World
Defense World
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Business Wire
Geron (NASDAQ:GERN) Trading 4.7% Higher - MarketBeat
MarketBeat
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
Benzinga
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday - Markets Insider
Markets Insider
Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me'
Benzinga
Jim Cramer Says This Tech Stock Is Great, Archer Aviation Is ‘Too Speculative For Me’ - Archer Aviation ( - Benzinga
Benzinga
The Latest Analyst Ratings For Geron
Benzinga
Geron to Participate at Upcoming Investor Conferences in April - Business Wire
Business Wire
Geron's Imetelstat Faces Full Gamut Of US FDA Questions At ODAC Meeting - Pink Sheet
Pink Sheet
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Zacks Investment Research
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval - sharewise
sharewise
Geron sets price for $150 million stock and warrant offering - Investing.com
Investing.com
Company News for Mar 18, 2024
Zacks Investment Research
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga
Choosing the Right Penny Stocks, 3 Hot Tips
PennyStocks
Company News for Mar 18, 2024 - Yahoo Finance
Yahoo Finance
Capitalizing on Market Cycles to Profit With Penny Stocks
PennyStocks
Inflation Squeezes Stocks, Bitcoin Slips To $68,000, While Commodities On Track For Best Week In Months: What's Driving Markets Friday?
Benzinga
Geron’s stock soars 95% after FDA advisory panel votes in favor of blood-disorder drug
MarketWatch
Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up
Zacks Investment Research
Biggest stock movers today: RIVN, ADBE, GERN, and more - Seeking Alpha
Seeking Alpha
Geron Stock Is Soaring After Hours: What's Going On?
Benzinga
FDA committee favors Geron's imetelstat for certain blood cancer - Investing.com UK
Investing.com UK
Implied Volatility Surging for Geron (GERN) Stock Options
Zacks Investment Research
Geron's drug for blood cancer patients faces FDA battle - San Francisco Business Times - The Business Journals
The Business Journals
FDA Casts Doubts On Geron's Blood Cancer Drug, But Analyst Sees High Probability For Imetelstat's Potential Approval For MDS Anemia Treatment
Benzinga
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
大文字化:
|
ボリューム (24 時間):